Thursday, May 16, 2019

CRISPR catches out critical cancer changes: New drug target for multiple cancers

In the first large-scale analysis of cancer gene fusions, researchers used CRISPR to uncover which gene fusions are critical for the growth of cancer cells. The team also identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian cancers. The results give more certainty for the use of specific gene fusions to diagnose and guide the treatment of patients.

from Latest Science News -- ScienceDaily http://bit.ly/30pQ4nW

No comments:

Post a Comment

Common pesticide linked to more than double the risk of Parkinson’s disease

Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s disease. People...